Literature DB >> 11014537

Role of hydrodynamic processes in the pathogenesis of peritumoral brain edema in meningiomas.

M Bitzer1, T Nägele, B Geist-Barth, U Klose, E Grönewäller, M Morgalla, E Heiss, K Voigt.   

Abstract

OBJECT: In a prospective study, 28 patients with 32 intracranial meningiomas were examined to determine the role of hydrodynamic interaction between tumor and surrounding brain tissue in the pathogenesis of peritumoral brain edema.
METHODS: Gadolinium-diethylenetriamine pentaacetic acid (Gd-DPTA), an extracellular contrast agent used for routine clinical imaging, remains strictly extracellular without crossing an intact blood-brain barrier. Therefore, it is well suited for investigations of hydrodynamic extracellular mechanisms in the development of brain edema. Spin-echo T1-weighted magnetic resonance images were acquired before and after intravenous administration of 0.2 mmol/kg Gd-DPTA. Additional T1-weighted imaging was performed 0.6, 3.5, and 6.5 hours later. No significant Gd-DPTA diffused from tumor into peritumoral brain tissue in 12 meningiomas without surrounding brain edema. In contrast, in 17 of 20 meningiomas with surrounding edema, contrast agent in peritumoral brain tissue was detectable after 3.5 hours and 6.5 hours. In three of 20 meningiomas with minimum surrounding edema (<5 cm3), contrast agent effusion was absent. After 3.5 hours and 6.5 hours strong correlations of edema volume and the maximum distance of contrast spread from the tumor margin into adjacent brain parenchyma (r = 0.84 and r = 0.87, respectively, p < 0.0001) indicated faster effusion in larger areas of edema.
CONCLUSIONS: The results of this study show that significant contrast agent effusion from the extracellular space of the tumor into the interstitium of the peritumoral brain tissue is only found in meningiomas with surrounding edema. This supports the hypothesis that hydrodynamic processes play an essential role in the pathogenesis of peritumoral brain edema in meningiomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11014537     DOI: 10.3171/jns.2000.93.4.0594

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: a preliminary study.

Authors:  M Inglese; S Brown; G Johnson; M Law; E Knopp; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas.

Authors:  Shinji Otsuka; Takashi Tamiya; Yasuhiro Ono; Hiroyuki Michiue; Kazuhiko Kurozumi; Shigeru Daido; Hirokazu Kambara; Isao Date; Takashi Ohmoto
Journal:  J Neurooncol       Date:  2004-12       Impact factor: 4.130

3.  Cytotoxic effects of statins and thiazolidinediones on meningioma cells.

Authors:  Sonja Gehring; Jorge Humberto Tapia-Pérez; Elmar Kirches; Raimund Firsching; Gerburg Keilhoff; Thomas Schneider; Christian Mawrin
Journal:  J Neurooncol       Date:  2010-08-30       Impact factor: 4.130

4.  Crush Cytology of Secretory Meningioma: A Case Report.

Authors:  Na Rae Kim; Gie-Taek Yee; Hyun Yee Cho
Journal:  Brain Tumor Res Treat       Date:  2015-10-30

5.  Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply.

Authors:  S Pistolesi; G Fontanini; T Camacci; K De Ieso; L Boldrini; G Lupi; R Padolecchia; R Pingitore; G Parenti
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

6.  Quantification of dispersion of Gd-DTPA from the initial area of enhancement into the peritumoral zone of edema in brain tumors.

Authors:  Igor N Pronin; Kathleen A McManus; Andrei I Holodny; Kyung K Peck; Valeri N Kornienko
Journal:  J Neurooncol       Date:  2009-03-29       Impact factor: 4.130

7.  Acute cerebral infarction masked by a brain tumor.

Authors:  Kwo-Whei Lee; Chung-Ping Lo
Journal:  Case Rep Neurol       Date:  2011-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.